Plain-English translation of NCT07226843 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This trial is testing a new medication called to see if it can help adults with certain types of blood cancers (like lymphoma) that have already been treated before. Researchers want to find the right dose, understand how safe the medication is, and whether it actually works to fight the cancer. Some participants will also receive the medication combined with another standard cancer treatment called .
Current treatment options for people with blood cancers that have already been treated are limited, and many patients relapse or don't respond well. This trial is exploring whether this medication could offer a new hope for people in this situation.
You likely qualify if…
You likely don't qualify if…
You would take the new medication by mouth, either alone or combined with an infusion of another drug, depending on which group you're assigned to. The study involves multiple visits over about 9 months or longer, during which researchers will check your blood work, scans, and overall health to see how well the medication is working and monitor for any side effects.
AI-generated summary from trial data · Jun 24, 2026 · Not medical advice
United States